Abstract
In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.
Original language | English (US) |
---|---|
Pages (from-to) | 885-907 |
Number of pages | 23 |
Journal | Transplantation and Cellular Therapy |
Volume | 27 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2021 |
Keywords
- BMT
- Cell Therapy
- Clinical Trial
- Humans
- Bone Marrow Transplantation
- Hematopoietic Stem Cell Transplantation
- Transplants
- Clinical Trials as Topic
ASJC Scopus subject areas
- Transplantation
- General Medicine
- Molecular Medicine
- Hematology
- Immunology and Allergy
- Cell Biology